Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Leukemia Research|November 22, 2019
BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemiasAline Massé, Louise Roulin, Justine Pasanisi, et al.
Biomedicines|November 27, 2021
Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)Hanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Cellular and Molecular Life Sciences : CMLS|February 3, 2022
Reliability of a novel approach for reference-based cell type estimation in human placental DNA methylation studiesLinda Dieckmann, Cristiana Cruceanu, Marius Lahti-Pulkkinen, et al.
British Journal of Haematology|June 19, 2013
Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-HématologiqueMichael Darmon, François Vincent, Laurent Camous, et al.
Blood|July 10, 2014
Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML IntergroupMarie-Anne Hospital, Thomas Prebet, Sarah Bertoli, et al.
Leukemia & Lymphoma|August 12, 2023
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpressionEytan M Stein, Stephane de Botton, Thomas Cluzeau, et al.
Oncotarget|May 18, 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemiaValérie Vidal, Guillaume Robert, Laure Goursaud, et al.
Blood|April 9, 2015
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemiaDorothée Selimoglu-Buet, Orianne Wagner-Ballon, Véronique Saada, et al.
Leukemia Research|February 29, 2016
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemiaJean-Baptiste Fraison, Arsène Mekinian, Eric Grignano, et al.
Pageof 15